A Comparative Study on Atorvastatin Versus Methotrexate in Rheumatoid Arthritis in a Double Blind Placebo Control Trial.

Author(s):
M SandooghiM Sandooghi1, Z Zakeri Z Zakeri 2,*, S Almasy S Almasy 3, AR Dashipour AR Dashipour 4
1Assistant Professor,
2Associate Professor, Section of Rheumatology, Department of In-ternal Medicine, Ali-Ebn-Abitaleb Hospital, Zahedan University of Medical Sciences, Za-hedan, Iran,
3Assistant Professor, Section of Rheumatology, Department of Internal Medicine, Firoozgar Hospital, Tehran University of Medical Sciences, Tehran, Iran,
4MSc in Nutrition , Zahedan University of Medical Sciences, Zahedan, Iran.

Shiraz E-Medical Journal:Vol. 12, issue 4; 189-95
Published online:Oct 01, 2011
Article type:Research Article
Received:Sep 26, 2010
Accepted:Oct 01, 2011
How to Cite:Sandooghi M, Zakeri Z, Almasy S, Dashipour A. A Comparative Study on Atorvastatin Versus Methotrexate in Rheumatoid Arthritis in a Double Blind Placebo Control Trial.. Shiraz E-Med J. 2011;12(4):. doi:

Abstract

Background:

The therapeutic effects of methotrexate (MTX) are well-known in rheumatoid arthritis(RA).Also,anti inflammatory effects of atorvastatin have already been reported, but no study has compared the effects of these two drugs on RA.Therefore we designed this study to compare the effects of these drugs on patients with active RA.

Method:

The study was conducted on 54 patients with active RA who had been undergoing Disease Modifying -Anti Rheumatic- Drugs therapy for at least 3 months that included 7.5 mg methotrexate weekly. They were allocated into two groups. In addition to the 7.5 mg of MTX, one group received another 7.5 mg of MTX weekly and placebo daily and the other group received atorvastatin 40 mg daily and placebo weekly. They were followed up for 12 weeks. Some clinical aspects and the disease activity score (DAS) were evaluated at the beginning of the study and then at the weeks of 6th and 12th.

Results:

After multiple comparisons by repeated measures, disease activity score and other variables showed a significant reduction in both groups at 12th week after treatment; however, the effect of both interventions was similar in change of DAS and other variables except for duration of morning stiffness, that it decreased more in statin than MTX group. No significant side effects causing to exclude the patients from the study were observed in any of the two groups.

Conclusion:

we concluded that statin, can serve an important role in treatment of RA.

Full Text

Full text is available in PDF

Similar Articles

25
May
2013

Efficacy of methotrexate in patients with polymyalgia rheumatica

Ali mohammad Nazarinia,
Jamileh Moghimi,
Jafar Toussi

Nazarinia AM, Moghimi J, Toussi J. Efficacy of methotrexate in patients with polymyalgia rheumatica. koomesh. 2013;14(3):e152575. doi:

27
Apr
2019

Efficacy of Methotrexate on Pain Severity Reduction and Improvement of Quality of Life in Patients with Moderate to Severe Knee Osteoarthritis

Afsaneh Enteshari-Moghaddam,
Khatereh Isazadehfar,
Afshin Habibzadeh,
Mehdi Hemmati

Enteshari-Moghaddam A, Isazadehfar K, Habibzadeh A, Hemmati M. Efficacy of Methotrexate on Pain Severity Reduction and Improvement of Quality of Life in Patients with Moderate to Severe Knee Osteoarthritis. Anesth Pain Med. 2019;9(3):e89990. doi: https://doi.org/10.5812/aapm.89990

27
May
2005

Comparison of Doxycycline and Azathioprine in the treatment of active rheumatoid arthritis

Z Zakeri,
Alireza khazaeia,
AA Kousari,
MR Taban

Zakeri Z, khazaeia A, Kousari A, Taban M. Comparison of Doxycycline and Azathioprine in the treatment of active rheumatoid arthritis. Zahedan J Res Med Sci. 2005;7(2):e94963. doi:

31
Oct
2015

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial

Mehdi Sayyah,
Hatam Boostani,
Mitra Ashrafpoori,
Siroos Pakseresht

Sayyah M, Boostani H, Ashrafpoori M, Pakseresht S. Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial. Iran J Pharm Res. 2015;14(4):e125389. doi: https://doi.org/10.22037/ijpr.2015.1748

31
Oct
2016

Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?

Shahnaz Bahadori,
Arman Ahmadzadeh,
Mohammad Reza Shams Ardekani,
Mohammad Kamalinejad,
Mansoor Keshavarz,
Jamshid Salamzadeh

Bahadori S, Ahmadzadeh A, Shams Ardekani MR, Kamalinejad M, Keshavarz M, et al. Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?. Iran J Pharm Res. 2016;15(4):e125228. doi: https://doi.org/10.22037/ijpr.2016.1924

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles